Genomic and Nongenomic Effects of Mifepristone at the Cardiovascular Level: A Review
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genomic and Nongenomic Effects of Mifepristone at the Cardiovascular Level: A Review
Authors
Keywords
-
Journal
Reproductive Sciences
Volume 24, Issue 7, Pages 976-988
Publisher
SAGE Publications
Online
2016-09-28
DOI
10.1177/1933719116671002
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mifepristone is a Vasodilator Due to the Inhibition of Smooth Muscle Cells L-Type Ca2+ Channels
- (2015) Melissa Mariana et al. Reproductive Sciences
- The Unique Pharmacological Characteristics of Mifepristone (RU486): From Terminating Pregnancy to Preventing Cancer Metastasis
- (2014) Jianzhong Chen et al. MEDICINAL RESEARCH REVIEWS
- Mifepristone: a potential clinical agent based on its anti-progesterone and anti-glucocorticoid properties
- (2013) Yayi Sun et al. GYNECOLOGICAL ENDOCRINOLOGY
- Testosterone and Atrial Natriuretic Peptide Share the Same Pathway to Induce Vasorelaxation of Human Umbilical Artery
- (2013) Joana Feiteiro et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Mifepristone for Management of Cushing's Syndrome
- (2013) Farah H. Morgan et al. PHARMACOTHERAPY
- GSTM1 Gene Expression Correlates to Leiomyoma Volume Regression in Response to Mifepristone Treatment
- (2013) Mikael Engman et al. PLoS One
- The use of the glucocorticoid receptor antagonist mifepristone in Cushingʼs syndrome
- (2013) Frederic Castinetti et al. Current Opinion in Endocrinology Diabetes and Obesity
- Non-genomic vasorelaxant effects of 17β-estradiol and progesterone in rat aorta are mediated by L-type Ca2+ current inhibition
- (2012) Elisa Cairrão et al. ACTA PHARMACOLOGICA SINICA
- First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review
- (2012) Elizabeth G. Raymond et al. CONTRACEPTION
- G protein-coupled oestrogen receptor 1 (GPER1)/GPR30: a new player in cardiovascular and metabolic oestrogenic signalling
- (2011) Bengt-Olof Nilsson et al. BRITISH JOURNAL OF PHARMACOLOGY
- Mifepristone (RU 486) induces vasodilation and inhibits platelet aggregation: nongenomic and genomic action to cause hemorrhage
- (2011) Mercedes Perusquía et al. CONTRACEPTION
- Effects of low-dose mifepristone administration in two different 14-day regimens on the menstrual cycle and endometrial development:a randomized controlled trial
- (2011) Yuezhou Chen et al. CONTRACEPTION
- Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety
- (2011) Philippe Bouchard et al. FERTILITY AND STERILITY
- Efficacy and Safety of Mifepristone for the Treatment of Psychotic Depression
- (2011) Christine M. Blasey et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Mifepristone: where do we come from and where are we going?
- (2010) Irving M. Spitz CONTRACEPTION
- Mifepristone: pharmacology and clinical impact in reproductive medicine, endocrinology and oncology
- (2010) Annie Im et al. EXPERT OPINION ON PHARMACOTHERAPY
- Mifepristone Reduces Weight Gain and Improves Metabolic Abnormalities Associated With Risperidone Treatment in Normal Men
- (2010) Coleman Gross et al. Obesity
- Mifepristone decreases depression-like behavior and modulates neuroendocrine and central hypothalamic–pituitary–adrenocortical axis responsiveness to stress
- (2010) Aynara C. Wulsin et al. PSYCHONEUROENDOCRINOLOGY
- Mifepristone treatment of olanzapine-induced weight gain in healthy men
- (2009) Coleman Gross et al. ADVANCES IN THERAPY
- Mifepristone: ten years later
- (2009) Eric A. Schaff CONTRACEPTION
- Minireview: Fetal-Maternal Hormonal Signaling in Pregnancy and Labor
- (2009) Carole R. Mendelson MOLECULAR ENDOCRINOLOGY
- Nongenomic uterine relaxing effect of RU 486 (mifepristone) prior to its antiprogesterone activity in the human pregnancy
- (2009) Mercedes Perusquía et al. STEROIDS
- A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormones
- (2008) Mary-Ellen Taplin et al. BJU INTERNATIONAL
- Systematic Expression Analysis and Antibody Screening Do Not Support the Existence of Naturally Occurring Progesterone Receptor (PR)-C, PR-M, or Other Truncated PR Isoforms
- (2008) Annemarie Samalecos et al. ENDOCRINOLOGY
- The effect of mifepristone on breast cell proliferation in premenopausal women evaluated through fine needle aspiration cytology
- (2008) M. Engman et al. HUMAN REPRODUCTION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started